Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout [0.03%]
非布索坦在治疗高尿酸血症和痛风中的应用证据分析
Angelo L Gaffo,Kenneth G Saag
Angelo L Gaffo
Introduction: Gout is a common and disabling cause of arthritis in middle-aged and elderly populations, with its main predisposing factor being hyperuricemia (serum urate > 6.8 mg/dL). Options for treatment of chronic gou...
Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect [0.03%]
静脉唑来膦酸治疗骨质疏松症的疗效证据
E Michael Lewiecki
E Michael Lewiecki
Introduction: Osteoporosis is a disease characterized by low bone mineral density and poor bone quality resulting in reduced bone strength and increased risk of fracture. Oral bisphosphonates, first-line therapy for most ...
Exforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact [0.03%]
氨氯地平缬沙坦复方制剂(Exforge)治疗高血压的疗效证据分析
Jean-Marie Krzesinski,Eric P Cohen
Jean-Marie Krzesinski
Introduction: Hypertension is an important risk factor for cardiovascular disease and its management requires improvement. New treatment strategies are needed. ...